145 related articles for article (PubMed ID: 32798077)
1. Efficacy of bezafibrate for preventing myopathic attacks in patients with very long-chain acyl-CoA dehydrogenase deficiency.
Shiraishi H; Yamada K; Egawa K; Ishige M; Ochi F; Watanabe A; Kawakami S; Kuzume K; Watanabe K; Sameshima K; Nakamagoe K; Tamaoka A; Asahina N; Yokoshiki S; Kobayashi K; Miyakoshi T; Oba K; Isoe T; Hayashi H; Yamaguchi S; Sato N
Brain Dev; 2021 Feb; 43(2):214-219. PubMed ID: 32798077
[TBL] [Abstract][Full Text] [Related]
2. Should the beneficial impact of bezafibrate on fatty acid oxidation disorders be questioned?
Bastin J; Bonnefont JP; Djouadi F; Bresson JL
J Inherit Metab Dis; 2015 Mar; 38(2):371-2. PubMed ID: 25310995
[No Abstract] [Full Text] [Related]
3. No effect of bezafibrate in patients with CPTII and VLCAD deficiencies.
Ørngreen MC; Vissing J; Laforét P
J Inherit Metab Dis; 2015 Mar; 38(2):373-4. PubMed ID: 25331908
[No Abstract] [Full Text] [Related]
4. Proposal for an individualized dietary strategy in patients with very long-chain acyl-CoA dehydrogenase deficiency.
Bleeker JC; Kok IL; Ferdinandusse S; de Vries M; Derks TGJ; Mulder MF; Williams M; Gozalbo ER; Bosch AM; van den Hurk DT; de Sain-van der Velden MGM; Waterham HR; Wijburg FA; Visser G
J Inherit Metab Dis; 2019 Jan; 42(1):159-168. PubMed ID: 30740737
[TBL] [Abstract][Full Text] [Related]
5. Bezafibrate activation of PPAR drives disturbances in mitochondrial redox bioenergetics and decreases the viability of cells from patients with VLCAD deficiency.
Lund M; Andersen KG; Heaton R; Hargreaves IP; Gregersen N; Olsen RKJ
Biochim Biophys Acta Mol Basis Dis; 2021 Jun; 1867(6):166100. PubMed ID: 33549744
[TBL] [Abstract][Full Text] [Related]
6. Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency.
Yamada K; Taketani T
J Hum Genet; 2019 Feb; 64(2):73-85. PubMed ID: 30401918
[TBL] [Abstract][Full Text] [Related]
7. Altered Energetics of Exercise Explain Risk of Rhabdomyolysis in Very Long-Chain Acyl-CoA Dehydrogenase Deficiency.
Diekman EF; Visser G; Schmitz JP; Nievelstein RA; de Sain-van der Velden M; Wardrop M; Van der Pol WL; Houten SM; van Riel NA; Takken T; Jeneson JA
PLoS One; 2016; 11(2):e0147818. PubMed ID: 26881790
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Can Be Improved by Lowering Accumulation of Fatty Acid Oxidation Intermediates.
Knottnerus SJG; Mengarelli I; Wüst RCI; Baartscheer A; Bleeker JC; Coronel R; Ferdinandusse S; Guan K; IJlst L; Li W; Luo X; Portero VM; Ulbricht Y; Visser G; Wanders RJA; Wijburg FA; Verkerk AO; Houtkooper RH; Bezzina CR
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32276429
[TBL] [Abstract][Full Text] [Related]
9. Adult-onset very-long-chain acyl-CoA dehydrogenase deficiency (VLCADD).
Fatehi F; Okhovat AA; Nilipour Y; Mroczek M; Straub V; Töpf A; Palibrk A; Peric S; Rakocevic Stojanovic V; Najmabadi H; Nafissi S
Eur J Neurol; 2020 Nov; 27(11):2257-2266. PubMed ID: 32558070
[TBL] [Abstract][Full Text] [Related]
10. Bezafibrate in skeletal muscle fatty acid oxidation disorders: a randomized clinical trial.
Ørngreen MC; Madsen KL; Preisler N; Andersen G; Vissing J; Laforêt P
Neurology; 2014 Feb; 82(7):607-13. PubMed ID: 24453079
[TBL] [Abstract][Full Text] [Related]
11. Very long-chain acyl-coenzyme A dehydrogenase deficiency in Chinese patients: eight case reports, including one case of prenatal diagnosis.
Li X; Ding Y; Ma Y; Liu Y; Wang Q; Song J; Yang Y
Eur J Med Genet; 2015 Mar; 58(3):134-9. PubMed ID: 25652019
[TBL] [Abstract][Full Text] [Related]
12. Molecular and cellular pathology of very-long-chain acyl-CoA dehydrogenase deficiency.
Schiff M; Mohsen AW; Karunanidhi A; McCracken E; Yeasted R; Vockley J
Mol Genet Metab; 2013 May; 109(1):21-7. PubMed ID: 23480858
[TBL] [Abstract][Full Text] [Related]
13. Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders.
Djouadi F; Aubey F; Schlemmer D; Ruiter JP; Wanders RJ; Strauss AW; Bastin J
Hum Mol Genet; 2005 Sep; 14(18):2695-703. PubMed ID: 16115821
[TBL] [Abstract][Full Text] [Related]
14. Molecular and clinical characteristics of very-long-chain acyl-CoA dehydrogenase deficiency: A single-center experience in Saudi Arabia.
Alhashem A; Mohamed S; Abdelraheem M; AlGufaydi B; Al-Aqeel A
Saudi Med J; 2020 Jun; 41(6):590-596. PubMed ID: 32518924
[TBL] [Abstract][Full Text] [Related]
15. Rare Korean Cases of Very-long-chain Acyl-CoA Dehydrogenase Deficiency with a Novel Recurrent Mutation.
Ko JM; Seo J; Choi M; Song J; Lee KA; Shin CH
Ann Clin Lab Sci; 2016; 46(1):97-101. PubMed ID: 26927351
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic challenge in very-long chain acyl-CoA dehydrogenase deficiency (VLCADD).
Hesse J; Braun C; Behringer S; Matysiak U; Spiekerkoetter U; Tucci S
J Inherit Metab Dis; 2018 Nov; 41(6):1169-1178. PubMed ID: 30194637
[TBL] [Abstract][Full Text] [Related]
17. Muscle MRI in patients with long-chain fatty acid oxidation disorders.
Diekman EF; van der Pol WL; Nievelstein RA; Houten SM; Wijburg FA; Visser G
J Inherit Metab Dis; 2014 May; 37(3):405-13. PubMed ID: 24305961
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency.
Diekman EF; Ferdinandusse S; van der Pol L; Waterham HR; Ruiter JP; Ijlst L; Wanders RJ; Houten SM; Wijburg FA; Blank AC; Asselbergs FW; Houtkooper RH; Visser G
Genet Med; 2015 Dec; 17(12):989-94. PubMed ID: 25834949
[TBL] [Abstract][Full Text] [Related]
19. The safety of Lipistart, a medium-chain triglyceride based formula, in the dietary treatment of long-chain fatty acid disorders: a phase I study.
MacDonald A; Webster R; Whitlock M; Gerrard A; Daly A; Preece MA; Evans S; Ashmore C; Chakrapani A; Vijay S; Santra S
J Pediatr Endocrinol Metab; 2018 Mar; 31(3):297-304. PubMed ID: 29425111
[TBL] [Abstract][Full Text] [Related]
20. Successful management of pregnancy with very-long-chain acyl-coenzyme A dehydrogenase deficiency.
Yamamoto H; Tachibana D; Tajima G; Shigematsu Y; Hamasaki T; Tanaka A; Koyama M
J Obstet Gynaecol Res; 2015 Jul; 41(7):1126-8. PubMed ID: 25655073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
